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Background: Up to 50% of penile squamous cell carcinomas (pSCC) develop in the context of high-risk human
papillomavirus (HR-HPV) infection. Most of these tumours have been reported to show basaloid differentiation and
overexpression of tumour suppressor protein p16INK4a. Whether HPV-triggered carcinogenesis in pSCC has an impact
on tumour aggressiveness, however, is still subject to research.
Methods: In tissue specimens from 58 patients with surgically treated pSCC between 1995 and 2012, we performed
p16INK4a immunohistochemistry and DNA extraction followed by HPV subtyping using a PCR-based approach. The
results were correlated with histopathological and clinical parameters.
Results: 90.4% of tumours were of conventional (keratinizing) subtype. HR-HPV DNA was detected in 29.3%, and
a variety of p16INK4a staining patterns was observed in 58.6% of samples regardless of histologic subtype. Sensitivity of
basaloid subtype to predict HR-HPV positivity was poor (11.8%). In contrast, sensitivity and specificity of p16INK4a staining
to predict presence of HR-HPV DNA was 100% and 57%, respectively. By focussing on those samples with intense
nuclear staining pattern for p16INK4a, specificity could be improved to 83%. Both expression of p16INK4a and
presence of HR-HPV DNA, but not histologic grade, were inversely associated with pSCC tumour invasion
(p = 0.01, p = 0.03, and p = 0.71). However, none of these correlated with nodal involvement or distant metastasis.
In contrast to pathological tumour stage, the HR-HPV status, histologic grade, and p16INK4a positivity failed to predict
cancer-specific survival.
Conclusions: Our results confirm intense nuclear positivity for p16INK4a, rather than histologic subtype, as a good
predictor for presence of HR-HPV DNA in pSCC. HR-HPV / p16INK4a positivity, independent of histological tumour grade,
indicates a less aggressive local behaviour; however, its value as an independent prognostic indicator remains to be
determined. Since local invasion can be judged without p16INK4a/HPV-detection on microscopic evaluation, our study
argues against routine testing in the setting of pSCC.
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Table 1 Clinico-pathologic sample characteristics
No. of patients 58
No. of samples 58
Age (mean; range) 64.5; 31-93 years
Tumour characteristics
Differentiation Distant metastasis
keratinizing 53 Mx 21
basaloid 5 cM0 33
Grading pM+ 4
Low-grade (G1-2) 43
High-grade (G3-4) 15 p16INK4a IHC
pT stage negative 24
pTis 10 positive 34
pTa 2 intense confluent 24
pT1 19 focally scattered 10
pT2 20
pT3 5
pT4 2 HPV subtyping
Nodal involvement HPV- 40
Nx 30 HPV+ 18
pN0 15 HPV-16 16
pN+ 13 HPV-45 1
HPV-6 1
pTis, carcinoma in situ; pTa, papillary/exophytic (noninvasive) carcinoma; pT1-
pT4, depth of tumor invasion; Nx, lymph node status unknown; pN0, (verified)
absence of lymph node metastases; pN+, (verified) presence of lymph node
metastases; Mx, presence of distant metastases unknown; cM0, no clinical
evidence for distant metastases; pM+, (verified) presence of distant metastases;
IHC, immunohistochemistry; HPV, human papillomavirus.
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Squamous cell carcinoma of the penis (pSCC) is associ-
ated with high morbidity and mortality and causes se-
vere psychological impact [1,2]. High-risk human
papillomavirus (HR-HPV) DNA is detectable in 30-80%
of pSCC surgical specimens [3]. In total, more than
17,000 cancer cases in European men per year are
attributable to HPV, with more than 15,000 of them be-
ing specifically attributable to HR-HPV-16 or -18 [4].
The benefit of early vaccination of girls and boys using
a quadrivalent HPV vaccine to prevent later occurrence
of HPV-related diseases is a current subject of discus-
sion [5]. Integration of HR-HPV DNA into the host cell
genome leads to overexpression of viral oncoproteins
E6 and E7 that exert a dysregulating effect on cell cycle
control [6]; upregulation of tumour suppressor protein
p16INK4a is understood as an attempt to stop uncon-
trolled cell proliferation in response to HPV infection
[7]. P16INK4a immunohistochemistry is therefore used
as a surrogate marker for high-risk HPV in cancers of
the cervix uteri and the head and neck region [8,9]. In
bladder cancer, however, we did not detect HPV DNA
in 29 samples of urothelial carcinoma in situ despite
diffuse intense confluent staining pattern for p16INK4a
[10]. Chaux et al. reported that in pSCC, HPV-
associated tumours are frequently composed of undif-
ferentiated warty or basaloid cells that show a variable
degree of koilocytic changes. The same group also
noted that non-HPV tumours are composed of keratin-
izing differentiated squamous cells [11]. Concerning
prognosis, HPV-driven squamous cell carcinomas of
the head and neck region (HNSCCs) are associated
with significantly improved progression-free survival
and disease-free survival [12]. On the other hand, pub-
lished data suggests a role for HPV-16 E6/E7 oncopro-
teins in the induction of epithelial-mesenchymal
transition which may contribute to cell migration and
metastasis [13,14]. Therefore, the impact of virus-
associated tumourigenesis on tumour aggressiveness,
metastatic potential, and patient prognosis in penile
cancer is still unclear, since only a few studies have ad-
dressed this topic, and the results are inconsistent
[15-17]. In the present study, we analysed pSCC tissue
samples for expression of p16INK4a and presence of
HPV DNA and correlated the results with tumour- and
patient-specific characteristics as well as cancer-specific
survival. We evaluated the value of histologic subtype
and various p16INK4a staining patterns as indicators for
the presence of HR-HPV DNA in tumour tissue, and
showed for the first time that presence of HR-HPV
DNA in pSCC is inversely associated with local tumour
invasion. Furthermore, we analysed the impact of HPV-
driven tumourigenesis on cancer-specific survival in
pSCC patients.Methods
Ethics statement
All specimens were surgically removed for therapeutic
purposes and subsequent histologic examination and
were thoroughly pseudonymized for the use in this
study. Therefore, individual written informed consent
was not mandatory. The study was approved by the
University of Ulm ethics committee (Approval No. 331/
2013).
Patient samples
Tissue samples from 58 patients were included in the
study; for all patients, biological parameters and tumour
characteristics were available. Patients underwent sur-
gery for penile cancer between 1995 and 2012 at the
Ulm University Medical Centre (n = 37) or at the Bun-
deswehrkrankenhaus Ulm (n = 21). All specimens had
been submitted for routine histologic examination to the
Institutes of Pathology of either the University of Ulm or
the Bundeswehrkrankenhaus Ulm. Clinico-pathological
characteristics are summarized in Table 1. TNM stages
were determined according to the UICC classification of
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(papillary/verrucous carcinoma) were summarized as
noninvasive, while pT1-pT4 stages were classified as inva-
sive lesions. Patient and tumour characteristics obtained
from the institutional databases included age, stage, and
the presence of histologically verified regional lymph node
involvement or distant metastasis, respectively. Of 35 pa-
tients (60.3% of the complete cohort; 23 HPV-negative
and 12 HPV-positive cases), complete follow-up data was
obtainable and reached up to 204 months (median/mean
follow-up 15/31 months).
Immunohistochemistry, image acquisition, and expression
analysis
Immunohistochemistry for p16INK4a was performed on a
BenchMark Autostainer (Ventana Medical Systems,
Tucson, USA) according to the manufacturer’s protocol
using a prediluted mouse monoclonal antibody (CINtec®
p16 Histology, clone E6H4, Ventana Medical Systems,
Tucson, USA). Microscopic slide evaluation/image ac-
quisition was performed using a Leica DM6000B light
microscope (Leica, Wetzlar, Germany) and the Diskus
Mikroskopische Diskussion image acquisition software
(Carl H. Hilgers, Königswinter, Germany). P16INK4a
staining patterns were classified in the following categor-
ies: a) intense confluent or b) focally scattered nuclear
and/or cytoplasmic staining pattern [19]. Histological
subtype, tumour grade and p16INK4a staining patterns
were confirmed by an experienced pathologist (PM).
Human papillomavirus (HPV) testing
HPV genotyping was performed as previously described
[10]. In short, DNA was extracted from tumour-
containing paraffin slides using the automated Maxwell®
16 FFPE Plus LEV DNA Purification Kit (Promega,
Madison, USA) and amplified with biotinylated primers;
PCR products were incubated with oligonucleotide-
precoated strips using the HPV typing kit from AID
diagnostics (Strassberg, Germany) according to the manu-
facturer’s protocol (Figure 1). The kit detects 15 different
HPV genotypes (6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53,
56, 58 and 59).Figure 1 Representative results of HPV genotyping using a PCR-based a
HPV DNA was detectable. Lane 3 shows detection of LR-HPV DNA that was laStatistical analysis
Correlations between dichotomous variables (histologic
subtype, p16INK4a positivity, HPV status, presence/absence
of tumour invasion, presence/absence of lymph node in-
volvement or distant metastasis, tumour differentiation
grade) were tested for significance using the Chi-Square/
Fisher’s exact test (SPSS, IBM, Ehningen, Germany). The
difference in disease-specific survival between low-grade/
high-grade, p16INK4a+/p16INK4a- and HPV+/HPV- groups
was assessed using LogRank test (SPSS, IBM, Ehningen,




The mean (median) age of the 58 patients included in
the study was 64.5 (64.0) years (IQR, 55.5-73.3 years,
Table 1). 43/58 (74.1%) samples were histologically clas-
sified as low-grade (G1-2) tumours; 53/58 (91.4%) of the
specimens showed keratinizing growth pattern with for-
mation of keratin pearls (Figure 2C), while 5/58 (8.6%)
tumours were of the basaloid subtype. Non-invasive
tumour growth (pTis/pTa stages) was observed in 12/58
(20.7%) samples. Presence of lymph node or distant me-
tastases was confirmed in pathological workup in 13
(22.4%) and 4 (6.9%) cases, respectively.
P16INK4a Immunohistochemistry
Altogether, positive immunostaining for p16INK4a was
observed in 34 (58.6%) tumour samples, with 30/53
(56.6%) tumours of the keratinizing subtype showing
some degree of positivity. However, there was a wide
variety in p16INK4a expression patterns (Figure 2): in-
tense confluent staining pattern (Figure 2B and C) was
detected in 24 of the 34 (70.6%) positive cases, while
weak or focal scattered staining (Figure 2D and E) was
observed in 10 (29.4%) samples. Among the cases with
ubiquitous strong expression in all tumour cells, there
was also a variety in cellular distribution of p16INK4a
from almost exclusively nuclear (3 cases, Figure 2F) to
intense cytoplasmic and nuclear positivity (22 cases,
Figure 2B and C). There was no significant associationpproach. First lane shows a HPV-16-positive case, while in lane 2, no
ter identified as HPV isoform 6. LR-HPV, low-risk human papillomavirus.
Figure 2 Representative microphotographs of pSCC specimens. A and B, penile squamous cell carcinoma in situ displaying strong, confluent
expression of p16INK4a. Note ascending p16INK4a positivity in non-malignant epithelium adjacent to carcinoma. C-F, variety of p16INK4a staining
patterns in pSCC: C, strong, confluent staining in invasive keratinizing carcinoma; D, diffuse and E, focally scattered positivity for p16INK4a; F, almost
exclusively nuclear immunostaining. Scale bars as indicated; H.E., haematoxylin-eosin; HR-HPV, high-risk human papillomavirus; pSCC, penile squamous
cell carcinoma.
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respective area of individual tumors (superficial/ exophytic
versus invasive areas).
HPV genotyping
Genomic subtyping following DNA extraction confirmed
presence of HPV DNA in 18 (31.0%) of 58 samples, 16
of which were classified as HPV-16 (Figure 1). One sam-
ple turned out to harbour HPV-45, while one case was
positive for HPV-6 DNA (low risk HPV). Notably, PCR
amplification of HPV-DNA was also successful in one
case where the paraffin block dated back to 1995.HPV status and clinic-pathological parameters
Basaloid histologic subtype of pSCC was not significantly
associated with presence of HR-HPV (HPV-16 or HPV-
45) in our study cohort (p = 0.62; Fisher’s exact test;
Table 2). Although the specificity of the basaloid growth
pattern for HR-HPV was 92.7%, since 28.3% of the kera-
tinizing tumours were also found to be HR-HPV positive,
sensitivity was only 11.8% (positive predictive value (PPV),
40%; Table 3). P16INK4a immunopositivity, irrespective of
the observed staining pattern, was significantly associated
with presence of HR-HPV DNA (p < 0.001; Fisher’s exact
test; Table 2). However, the PPV of p16INK4a staining for
presence of HR-HPV was only 52.9% (sensitivity, 100%;




basaloid 3 2 0.62
Grading
Low-grade (G1-2) 32 11
High-grade (G3-4) 9 6 0.33
Presence of tumour invasion
Non-invasive 5 7
Invasive 36 10 0.028
Presence of metastasis
N0M0 10 5




intense nuclear/confluent 7 17 <0.001
*Fisher’s exact Test.
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by focusing on cases with intense nuclear and confluent
staining patterns in all tumour cells (PPV, 75%; specificity,
85%; Table 3). Histopathologic tumour grade was not
significantly associated with presence of HPV DNA.
HR-HPV positivity and nuclear p16INK4a staining, but
not histologic differentiation grade, was significantly as-
sociated with non-invasive tumour growth (pTis/pTa
stage; p = 0.03, p = 0.01, and p = 0.71). For verified
nodal involvement or distant metastasis, there was no
significant association with HPV status, p16INK4a posi-
tivity or grade of differentiation of the primary tumour
(p = 0.22, p = 0.25, and p = 0.41; Fisher’s exact test).
HPV status and cancer-specific survival
Follow-up data was obtainable for 35 patients and
reached up to 204 months. No patient in the HPV-
positive group, but 6 patients in the HPV-negative group
died from the disease (Figure 3). However, this difference
failed to reach significance in Kaplan-Meier analysis
(p = 0.13; Log Rank test). In contrast to pathologicalTable 3 Test statistics for basaloid histologic subtype and








Basaloid histologic subtype 40 11 95
Any positivity for p16INK4a 53 100 60
Intense nuclear p16INK4a staining 75 100 85tumour stage including all stages (p = 0.01), p16INK4a
positivity and histologic differentiation grade (G1-2 vs.
G3-4) were also not significantly associated with cancer-
specific survival (p = 0.49 and p = 0.15, respectively).
Discussion
The role of human high-risk papillomavirus infection as
a causative agent in the development of penile squamous
cell carcinoma is well established [20]. However, the im-
pact of HPV-related tumourigenesis on tumour morph-
ology as well as aggressiveness is still subject to research
and has led to contradictory results [15-17]. Moreover, it
is still not clear to which extent immunostaining for
p16INK4a might be regarded as a surrogate marker for
HPV infection, since site-specific differences in sensitiv-
ity and specificity have been reported [10,21-23]. The
observed variety of staining patterns for p16INK4a further
complicates histologic evaluation [24,25]. Therefore, the
aim of this study was to evaluate p16INK4a staining pat-
terns and results from HPV DNA subtyping with histo-
pathological and clinical characteristics in a cohort of 58
patients with penile squamous cell carcinoma (pSCC).
Among the study cohort, 91% of pSCCs were classified
as conventional-type (keratinizing pSCC) because vari-
ous degrees of keratinization could be observed in these
cases. This is a higher proportion than has been de-
scribed in earlier studies, while the rate of basaloid-type
tumours was comparable to data from literature
[11,16,26]. HPV DNA (of any subtype) was detected in
31% of all cases, with HR-HPV DNA (HPV-16 and
HPV-45) being present in 28% of conventional-type and
40% of basaloid-type carcinomas. Thus, despite a specifi-
city of 95% and a positive predictive value of 40%, the
resulting sensitivity of basaloid tumour differentiation
for the presence of HR-HPV DNA was only 11%. Due to
the significant proportion of conventional-type (keratin-
izing) tumours that turned out HPV-positive in PCR-
based assays, our results do not support the correlation
between presence of HR-HPV DNA and basaloid
tumour subtype that has been previously described by
other authors. This might be due to the fact that distin-
guishing one histological type from another can be chal-
lenging, and overlapping differentiation patterns as well
as intratumoural heterogeneity exist [27]. Therefore, we
would not recommend to rely solely on basaloid tumour
subtype when assessing hints for HPV-driven tumouri-
genesis as proposed by some authors but rather use a
combination of criteria as proposed in a 2014 study by
Chaux et al. [28,29]. Positive immunostaining for
p16INK4a, a tumour suppressor protein that is regarded
as a surrogate marker for HPV-associated tumours in
other organs [7,30], was observed in 59% of specimens.
There was a wide variety from scattered-focal over
confluent-intense to almost exclusively nuclear staining
Figure 3 Cancer-specific survival analysis. A-I and -II, Cancer-specific survival depending on histopathologically confirmed T stage as indicated;
B, depending on histopathologic differentiation grade; C, depending on p16INK4a expression; D, depending on HR-HPV status. G1-4, histopathologic
differentiation grade; HR-HPV, high-risk human papillomavirus.
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cantly with the presence of HR-HPV DNA with good
sensitivity (100%), but lacked specificity (60%) when all
staining patterns were considered (PPV, 53%). Consider-
ing only those specimens with intense nuclear positivity
for p16INK4a in all tumour cells improved the specificity
for the presence of HR-HPV DNA to 85% (PPV, 75%).
P16INK4a was present in all HPV-positive cases; however,
lack of p16INK4a immunostaining in HPV-associated tu-
mours due to loss of heterozygosity near the CDKN2A
locus and/or hypermethylation of the CDKN2A pro-
moter has been described previously [31]. It is therefore
well conceivable that these genetic aberrations accumu-
late stepwise during tumour progression, and could not
be observed here due to the relatively large proportion
of early/noninvasive HPV-positive tumours in our study.
Also, it has to be stated that we did not examine
p16INK4a expression in corresponding metastases, but a
2014 study showed identical immunohistochemical or
HPV in situ hybridization profiles between primary
pSCCs and their corresponding metastases [32]. How-
ever, the question remains if there is a prognostic value
of HR-HPV-driven tumourigenesis in pSCC at all. To
address this, we investigated whether presence of HR-
HPV DNA was associated with tumour aggressiveness or
cancer-specific survival in pSCC. We found that HR-HPV
as well as p16INK4a positivity was significantly associated
with non-invasive tumour growth (pTis/pTa stage). This
finding is in contrast to a proposed proinvasive role for
HPV oncoproteins that has been recently described in
head and neck as well as cervical cancer, but is supported
by data for penile cancer published by other authors
[13,16,33-35]. Our findings therefore add to the growing
evidence that there are site-specific differences in the role
of HPV regarding the gain of an invasive phenotype.
These differences may be linked to interaction of HPV-
derived oncoproteins with β-integrin localization and sig-
nalling [36]. For nodal or distant metastasis, there was no
significant correlation with presence of HR-HPV DNA,
p16INK4a staining or histologic grade in our sample set;
similar results have been previously described [37]. Fur-
thermore, we detected no significant differences in cancer-
specific survival with regard to histologic differentiation
grade, or p16INK4a positivity. This is in line with some pre-
vious studies that failed to confirm a proposed association
between histopathologic grade and lymph node metastasis
or overall survival in pSCC, while it has to be stated as a
clear limitation of our study that follow-up data was only
obtainable for 35 patients (60.3%) [38-40]. Considering the
substantial interobserver variability that has been
described for histopathologic grading in pSCC (between
59-87% with ĸ = 0.38-0.69 [41]), we think that the current
histopathologic grading is of limited value due to an obvi-
ous lack of prognostic relevance; this conclusion is alsosupported by other authors [42]. For the presence of HR-
HPV we observed a trend towards better prognosis that
failed to reach statistical significance; further investigations
in larger cohorts might therefor be indicated.
Conclusion
In this study, we evaluate histologic subtyping as well as
p16INK4a immunostaining for detection of HR-HPV DNA
and propose that ubiquitous nuclear expression of
p16INK4a is a strong predictor for the presence of HR-HPV
in penile squamous cell carcinoma. We further show that,
in contrast to histologic grading, presence of HR-HPV
DNA is associated with noninvasive growth of the tumour.
However, since there was no significant impact of HPV-
driven tumourigenesis on metastasis and cancer-specific
survival in pSCC, routine p16INK4a immunostaining or
HPV genotyping in pSCC cannot be recommended.
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